Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03730012 |
|---|---|
| Brief Title: | A Study of ASP2215 (Gilteritinib) Combined With Atezolizumab in Patients With Relapsed or Treatment Refractory FMS-like Tyrosine Kinase (FLT3) Mutated Acute Myeloid Leukemia (AML) |
| First Submitted : | November 1, 2018 |
| First Submitted that Met QC Criteria : | November 1, 2018 |
| First Posted : | November 5, 2018 |
| Last Update Submitted that Met QC Criteria : | April 8, 2021 |
| Last Update Posted : | April 9, 2021 (Estimate) |